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Two-pore domain K+ (KCNK, K2P) channels underlie the “leak” (background) potassium
conductance in many types of excitable cells. They oppose membrane depolarization and
cell excitability. These channels have been reported to be modulated by several physical
and chemical stimuli. The compound 2-aminoethoxydiphenyl borate (2-APB) was originally
described as an inhibitor of IP3-induced Ca2+ release but has been shown to act as either a
blocker or an activator for several ion channels. Here, we report the effects of this compound
on members of theTREK (TWIK related K+ channels) subfamily of human KCNK channels.
We injected Xenopus laevis oocytes with cRNAs (complementary RNAs) encoding several
KCNK channels and measured their response using the two-electrode voltage clamp
technique. 2-APB was found to be an effective activator for all members of the TREK
subfamily (hKCNK2, hKCNK4, and hKCNK10), with the highest efﬁcacy in hKCNK10. We
also found that 2-APBwas able to activate these channels in cell-excised patches of HEK293
(human embryonic kidney 293) cell transfected with hKCNK4 or hKCNK10, demonstrating
direct activation. TREK channels are widely expressed in the central nervous system and
peripheral tissues, where they play roles in several key processes. However, little is
known regarding their pharmacology; therefore, the identiﬁcation of a common, stable
and inexpensive agonist should aid further investigations of these channels. Additionally,
2-APB has been used to study native receptors in cell systems that endogenously express
members of theTREK subfamily (e.g., rat dorsal root ganglia); our results thus warn against
the use of 2-APB at high concentrations in these systems.
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INTRODUCTION
KCNK channels (also known as K2P, for two-pore domain potas-
sium channels) are potassium selective channels that tend to be
constitutively open. Most of them behave as outward rectiﬁers
under physiological K+ concentrations. Additionally, they also
behave in an almost voltage-independent manner (Enyedi and
Czirják, 2010). Because of these characteristics, they are consid-
ered the main channels responsible for the leak potassium current
that helps maintain the resting membrane potential. This leak
current exerts control over neuronal excitability by shaping the
duration, frequency, and amplitude of action potentials (Gold-
stein et al., 2001). An increased K+ leak current stabilizes the cell
at hyperpolarized voltages below the ﬁring threshold, whereas leak
suppression permits or facilitates depolarization. In this manner,
KCNK channels play a role in such diverse processes as metabolic
regulation, apoptosis, thermoperception, and chemoperception
(Lotshaw, 2007).
The mechanically gated TREK (for TWIK related K+ chan-
nels) subfamily of KCNK channels is composed of three mem-
bers: TREK-1 (KCNK2), TRAAK (KCNK4), and TREK-2
(KCNK10) with several functional splice variants reported for
hTREK-1 and hTREK-2 (Gu et al., 2002; Xian Tao et al., 2006).
Although members of the TREK subfamily differ slightly in their
electrophysiological properties, they show similar characteristics,
such as mechano- and thermosensitivity. They also present
overlapping pharmacological patterns, characterized by a mild
sensitivity to standard potassium channel blockers such as quini-
dine and Ba2+ and sensitivity to volatile anesthetics like halothane
(Lotshaw, 2007). TREK channels are widely expressed in both the
peripheral and the central nervous system (CNS; Medhurst et al.,
2001). Recent studies with TREK−/− mice have demonstrated
that TREK channels are necessary for appropriate mechano- and
thermoperception (Alloui et al., 2006; Noël et al., 2009).
2-Aminoethoxydiphenyl borate (2-APB) was originally
described as a membrane-permeable modulator of Ins(1,4,5)P3-
induced Ca2+ release (Maruyama et al., 1997). Although this
function has been questioned, 2-APB is agreed to inhibit the
store-operated current observed after depletion of ER Ca2+ stores
(Dobrydneva and Blackmore, 2001); it also blocks certain tran-
sient receptor potential (TRP) channels belonging to the canonical
(TRPC), and melastatin (TRPM) subfamilies (Hu et al., 2004)
and certain voltage-gated potassium channels present in Limu-
lus ventral photoreceptors (Wang et al., 2002). It is also a common
activator for the TRPV1 (transient receptor potential vanilloid 1),
TRPV2, and TRPV3 channels (Hu et al., 2004). Interestingly, the
perception of noxious heat, in which TRPV1 and TRPV2 play
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a key role, has been shown to be modulated or ﬁne-tuned by
KCNK2andKCNK4 (Noël et al., 2009). Both theTREKandTRPVs
subfamilies have been shown to be coexpressed at the neuronal
level in the rat trigeminal ganglia (Yamamoto et al., 2009). With
this background in mind, we addressed the question of whether
2-APB has an effect on human KCNK channels of the TREK
subfamily. We found that 2-APB activates all members of this sub-




hKCNK4 cloned into pBluescript SK+, hCKNK10 cloned
into pCR4-TOPO and hKCNK2 cloned into pDNR-dual were
purchased from Imagenes (Berlin, Germany). hKCNK2 and
hKCNK10 cDNA inserts were afterward subcloned into pSGEM
for electrophysiological recordings in Xenopus oocytes. The plas-
mids were linearized with NotI for pBluescript SK+ and PacI for
pSGEM, providing linear cDNA templates for in vitro transcrip-
tion. All three hKCNK inserts were subsequently subcloned into
pCDNA3 for electrophysiological recordings in human embryonic
kidney 293 (HEK293) cells.
hKCNK3 cloned into the expression vector pIRES-CD8 was a
gift from Dr. Fabrice Duprat (Institut National de la Santé et de
la Recherche Médicale, Antipolis, France). hKCNK18 cloned into
the plasmid pEXO was a gift from Professor Dr. P. Enyedi (Sem-
melweis University, Budapest, Hungary). hKNCK9 cloned into
the expression vector pCR4-TOP, was purchased from Imagenes
(Berlin, Germany). The plasmids were linearized with the restric-
tion enzymes BamHI, XhoI, and SspI, respectively, and then used
as templates for in vitro transcription.
Capped RNAs were synthesized in the presence of capping ana-
log m7G(5′)ppp(5′)G using the AmpliCap-T7 Message Maker kit
(Epicentre, Madison, WI, USA). Complementary RNA (cRNA)
was dissolved in nuclease-free water to give a ﬁnal concentration
of 500 ng/μL.
Xenopus laevis OOCYTE PREPARATION
Complementary RNAs were expressed in X. laevis oocytes essen-
tially as described by Vogt-Eisele et al. (2007). Brieﬂy, mature
female X. laevis frogs were anesthetized with 0.15% MS-222,
surgery was performed according to standard methods, and the
extracted ovarian lobes were placed into Ca2+-free Barth´s solu-
tion containing collagenase type II (Worthington Biochemical
Corporation) and incubated for 90 min on a shaker at 40 rpm
(room temperature). After that time, healthy stage V and VI
oocytes were selected for injection with cRNA coding for the pro-
teins of interest; 30 nL of cRNA (100 ng/μL) for each channel
was injected using a Microinjector Micro 4 TM (World Preci-
sion Instruments). After injection, the oocytes were incubated
in ND96 (96 mM NaCl; 2 mM KCl; 1.8 mM CaCl2; 1 mM
MgCl2; 2.5 mM sodium pyruvate 3 mM, 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) 10 mM, pH 7.2), and
measurements were performed 24–72 h after injection.
The oocytes were placed in a 100 μL chamber perfused with
frog Ringer’s solution (115 mM NaCl; 2.5 mM KCl; 1.8 mM
CaCl2, and 10 mM HEPES pH 7.2); this solution was also used
to dissolve the applied chemicals. For recording, a Turbo Tec-03x
(npi electronic GmbH) ampliﬁer was used. Borosilicate glass
capillaries were pulled with a Kopf vertical pipette puller. For
the voltage clamp, the pulled glass capillaries were ﬁlled with
3 M KCl.
TWO-ELECTRODE VOLTAGE CLAMP MEASUREMENTS
A ramp series protocol was used to evaluate the activity of the
channels. The voltage ramps consisted of a starting constant volt-
age of −100 mV for 300 ms, followed by a ramp to +50 mV in
700 ms, then a constant voltage at +50 mV for 300 ms, and a ﬁnal
constant voltage at −40 mV for 300 ms. The time interval between
the ramps was of 2 s. In order to evaluate the effect of a substance
on the basal current, we took the average of the currents regis-
tered during the last 30 ms of the +50 mV constant from the three
ramps that showed the maximal response to the applied substance
and divided it by the average obtained from three ramps prior to
the application.
The data were collected using the Cellworks Reader 3.7 soft-
ware (npi instruments, Germany) and analyzed with Clampﬁt
v10.2.0.14 (MDS Analytical Technologies). Curve ﬁtting was per-
formed using the Hill equation (Sigmaplot 8, Systat software
inc.). Data are expressed as means ±SEM (standard error of the
mean). A paired t-test was used to evaluate the statistical signif-
icance of the results, and P < 0.05 was considered statistically
signiﬁcant and is marked with one star, P < 0.01 is marked with
two stars, and P < 0.001 is marked with three stars.
CELL CULTURE
Human embryonic kidney 293 cells were grown in Dulbecco’s
modiﬁed Eagle’s medium containing 10% fetal bovine serum,
2mM L-glutamine, and 100μg/mLpenicillin/streptomycin (Invit-
rogen, Karlsruhe, Germany) at 37◦C in a humidity-controlled
incubator with 5% CO2.
TRANSIENT EXPRESSION OF HUMAN KCNK2, KCNK4, AND KCNK10 IN
HEK293 CELLS
For transient expression of human KCNK2,KCNK4, and KCNK10
in HEK293 cells, we used the recombinant expression plasmid
pCDNA3. HEK293 cells were transiently transfected (8 μg of
hKCNK4 cDNA in pCDNA3 per dish) in 35-mm dishes (Falcon,
BD Bioscience,Heidelberg, Germany) using the CaP-precipitation
method described previously by Dörner et al. (2007). These cells
were cotransfectedwithpIRES-EGFP (1μgper dish),which served
as a transfection marker. All recordings were performed 18–24 h
after transfection.
ELECTROPHYSIOLOGY IN HEK293 CELLS
Recordings were performed using the whole-cell and inside-out
modes of the patch-clamp technique. Cells were maintained in
an extracellular recording solution containing (in mM) 140 NaCl,
5 KCl, 2 MgCl2, 2 CaCl2, 10 HEPES, and 10 glucose, pH 7.4.
Patch electrodes were pulled from borosilicate glass (1.2 mm
OD×1.17mmID;Harvard apparatus, Edenbridge,Kent,UK) and
ﬁre polished to 4–6 M tip resistance using a horizontal pipette
puller (Zeitz Instruments, Munich, Germany) in order to obtain a
patch of approximately 1–2 μm diameter.
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FIGURE 1 | (A) Effect of 1 mM 2-APB on (from left to right) uninjected
Xenopus oocytes and oocytes injected with cRNA coding for hKCNK2,
hKCNK3, hKNCK4, hKCNK9, hKCNK10, and hKCNK18. For each group, the
current registered at the ﬁnal 50 ms of the +50 mV constant (see
experimental procedures for a description of the ramp protocol used) was
normalized to the current registered prior to the application of 2-APB
(dotted line). All data are expressed as means ±SEM. Number of cells in
each experiment is indicated above the bars. (B) Absolute currents
registered in uninjected Xenopus oocytes and oocytes injected with cRNA
coding for hKCNK2, hKCNK4, and hKNCK10, before and after the
(Continued)
Figure 1 | Continued
application of 1 mM 2-APB. (C) Representative I-V trace of a Xenopus
oocyte expressing hKCNK10 before (black line), and after the application of
2-APB at 600 μM (green line), and 6 mM (blue line). (D) Ramp series
measurement of a Xenopus oocyte expressing hKCNK10 that was
repeatedly exposed to 1 mM 2-APB. The dotted green line represents zero
current. (E) 1 mM 2-APB reversibly hyperpolarizes a Xenopus oocyte
expressing hKCNK10. (F) Dose–response curve ﬁtted to the 4-parameter
Hill equation (n indicated above the points). (G) Effect of 2-APB at 100 μM
(left) and 300 μM (right) on Xenopus oocytes injected with cRNA coding for
hKCNK2, hKNCK4, and hKCNK10. Data were normalized to the current
registered prior to the application of 2-APB (dotted line). All data are
expressed as means ±SEM. Number of cells in each experiment is
indicated above the bars. (H) Inside-out patch-clamp recordings of
cell-excised patches from untransfected HEK293 cells (left) and HEK293
cells transfected with hKCNK10 (right) before and after exposure to
3 mM 2-APB.
For recordings, the pipette solution contained (in mM) 140
KCl, 1 MgCl2, and 10 HEPES, pH 7.4. All recordings were per-
formed at room temperaturewith anEPC7ampliﬁer (List-Medical
Electronic, Darmstadt, Germany). For whole-cell patch-clamp
recordings, a step protocol consisting of a holding potential of
−60 mV, followed by 20 mV steps of 400 ms duration from
−110 mV to +50 mV was used. Because the current registered
at the last two steps continued to increase and never presented
a stable baseline, the last 50 ms of the +10 mV step were
selected in order to build a dose–response curve. Cell-excised
patches were evaluated in the inside-out conﬁguration, at a hold-
ing potential of 0 mV. Data were acquired using Pulse software
(HEKA, Lambrecht, Germany). All data are expressed as means
±SEM.
CHEMICALS
2-Aminoethoxydiphenyl borate and dimethyl sulfoxide (DMSO)
were purchased from Sigma-Aldrich (Munich, Germany). Stock
solutions of 100 mM and 300 mM 2-APB diluted in DMSO were
made and stored at −20◦C; the latter was used for preparing
solutions containing 3 and 10 mM 2-APB.
RESULTS
2-APB ACTIVATES ALL MEMBERS OF THE TREK
SUBFAMILY
First, we studied the effect of 1 mM 2-APB on X. laevis oocytes
injected with cRNAs coding for each member of the TREK sub-
family (KCNK2, KCNK4, and KCNK10), two members of the
TASK subfamily (KCNK3 and KCNK9), the only member of
the TRESK subfamily (KCNK18) and a control group of non-
injected oocytes (see Figure 1A). Oocytes injected with KCNK18
were not affected by 2-APB, whereas those injected with either
member of the TASK subfamily were mildly inhibited by 2-APB.
The currents presented by uninjected oocytes were negligible
in comparison with the currents of oocytes injected with any
of the aforementioned hKCNK channels; however, these cur-
rents were mildly but signiﬁcantly inhibited by 1 mM 2-APB,
reducing their basal activity to 70.3% (Figure 1B). 2-APB, how-
ever, increased the basal activity of hKCNK2, hKCNK4, and
hKCNK10 by factors of 2.22 ± 0.2, 2.68 ± 0.2, and 4.35 ± 0.8,
respectively.
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2-APB ACTIVATES hKCNK10 CHANNELS IN A DOSE-DEPENDENT
MANNER
We then proceeded to study in detail the effect of 2-APB on
hKCNK10. hKCNK10, also known as TREK-2, is expressed
throughout the human CNS. It is one of the major background K+
channels in dorsal root ganglion neurons (Kang and Kim, 2006),
and it is also expressed in the kidneys, spleen, and small intes-
tine (Medhurst et al., 2001). 2-APB produced a dose-dependent
(Figure 1C) and reversible activation of hKCNK10 that was unal-
tered after repeated applications (Figure 1D). Consequently with
this,whenwe recorded themembranepotential of oocytes express-
ing hKCNK10, we observed that 1 mM 2-APB produced a strong
and quick hyperpolarizing effect that reversed almost completely
after washout (Figure 1E). The dose–response curve gave an EC50
of 1.22 ± 0.39 mM; the maximal effect (seen at around 3 mM)
was a 14-fold increase in the basal current (Figure 1F). Lower
concentrations, however, also led to signiﬁcant changes in the
basal activity of hKCNK10, as this was increased by factors of
1.33 ± 0.2 and 2.25 ± 0.4 by the application of 100 μM and
300 μM, respectively (Figure 1G). Because the highest concen-
tration of 2-APB that was evaluated required a concentration of
the vehicle compound DMSO higher than 1% (3.3% DMSO for
10 mM 2-APB), we evaluated the effect of this vehicle at its highest
concentration used and compared this effect with both the basal
current prior to application and basal current after the application
of the same solution containing 2-APB (Figure 3B). We found
no signiﬁcant difference in the basal current prior and after the
application of 3.3% DMSO for 10 s; this was true for both injected
and uninjected oocytes (Figure 3A).
To determine whether this effect depended on the presence
of any cytosolic factor, we proceeded to transfect HEK293 cells
with hKCNK10 and measured cell-excised patches in the inside-
out conﬁguration, exposing them to 3 mM 2-APB (1% DMSO).
Untransfected HEK293 showed no signiﬁcant response to 3 mM
2-APB (Figure 1H, left). Transfected HEK293 cells showed
open channel noise, as previously described (Bang et al., 2000),
which was markedly increased after the application of 3 mM 2-
APB (Figure 1H, right), demonstrating the direct nature of the
interaction.
2-APB ACTIVATES hKCNK2 AND hKCNK4 CHANNELS IN A
DOSE-DEPENDENT MANNER
We also investigated the effect of 2-APB on the other two members
of the TREK subfamily. These are hKCNK2 (hTREK-1), which
is the most thoroughly studied KCNK channel, and hKCNK4
(hTRAAK), which received its name because of its sensitivity to
arachidonic acid, though it is also sensitive to other polyunsatu-
rated fatty acids. Both channels are active at physiological body
temperatures and have been shown to be necessary for appro-
priate thermoperception (Noël et al., 2009). Like KCNK10, they
are expressed in both the central and peripheral human nervous
system (Medhurst et al., 2001).
2-Aminoethoxydiphenyl borate induced dose-dependent and
partially reversible activation of hKCNK2 and hKCNK4 in X.
laevis oocytes expressing these channels (see Figure 2A). As for
hKCNK10, 2-APB elicited more pronounced activation of these
two channels at potentials above the Krev (Figure 2B). 2-APB had
FIGURE 2 | (A) Representative traces showing the effect of increasing
concentrations of 2-APB on hKCNK4-expressing (top) and
hKCNK2-expressing (bottom) Xenopus oocytes subjected to the ramp
series protocol described in the experimental procedures. (B)
Representative I–V traces for the excitatory effect of increasing
concentrations of 2-APB on oocytes expressing hKCNK2 (left) and hKCNK4
(right). (C) Dose–response curve showing the effects of 2-APB on hKCNK2
and ﬁtted to the 4-parameter Hill equation (n indicated above the points).
(D) Dose–response relationship showing the effect of 2-APB on hKCNK4 (n
indicated above the points). (E) Dose–response relationship showing the
effect of 2-APB on hKCNK4 (n = 3–5 HEK293 cells). (F) Inside-out
patch-clamp recordings of cell-excised patches from hKCNK4-expressing
HEK293 cells before and after exposure to 3 mM 2-APB.
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FIGURE 3 | (A) Comparison of the effects of applying 100 μL frog Ringer’s
solution containing 3. 3% DMSO vs. applying the same solution plus 10 mM
2-APB to uninjected oocytes (gray bars) or oocytes injected with cRNA coding
for hKCNK2 (light green bars) and hKCNK10 (dark green bars) (n = 3–5
oocytes/group). The time of exposure was approximately 10 s. (B)Top:
Representative voltage clamp recording from an oocyte expressing hKCNK2
exposed to vehicle solution (green rectangles) or the same solution plus
10 mM DMSO (blue rectangles). Bottom: Representative voltage clamp
recording from an inside-out patch-clamp of a HEK293 cell expressing
hKCNK10, before and after exposure to 1% DMSO (light green rectangle).
(C) hKCNK4 currents recorded from a transfected HEK293 cell before (right)
and after (left) the application of 300 μM 2-APB. Currents were elicited by
voltage pulses from −110 to +50 mV in 20 mV steps, 400 ms in duration,
from a holding potential of −60 mV.
an EC50 of 486 ± 135 μM for hKCNK2 (Figure 2C); however, an
EC50 value for hKCNK4 could not be determined, although this
channel was clearly activated in a dose-dependent manner by 2-
APB in bothX. laevis oocytes (Figure 2D) and transfectedHEK293
cells (Figures 2E and 3C for original trace). Like hKCNK10,
hKCNK4 also showed a marked increase in basal activity when
treated with 2-APB in inside-out excised patches from transfected
HEK293 cells, suggesting that this effect is independent of cytosolic
factors (Figure 2F).
DISCUSSION
Members of the TREK subfamily of KCNK channels are widely
expressed in the CNS (Medhurst et al., 2001), where they have
been shown to play a key role in several processes ranging from
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long-term depression to neuroprotection (Heurteaux et al., 2006;
Kim et al., 2011). This makes them valuable targets for phar-
macological research; however, little is known regarding their
pharmacology, and common and stable activators are lacking.
Here we have showed that the membrane-permeable substance
2-APB behaves as a highly effective activator for all the mem-
bers of the mechano-gated TREK subfamily of human KCNK
channels. 2-APB must now be regarded as a pharmacological
tool for the study of members of the TREK subfamily. Also, its
pharmacological characteristics might be useful for drug design.
Interestingly, we also found that 2-APB can block certain unidenti-
ﬁed endogenous channel(s) in X. laevis oocytes. This effect should
be taken into consideration when using this system to evaluate
2-APB at high concentrations, especially when characterizing the
effects of 2-APB on heterologously expressed channels (e.g., TRPC
and TRPM channels).
The basal activity of hKCNK10 was increased up to 2.3- and 14-
fold when exposed to 300μM and 3 mM 2-APB, respectively. This
is expected to signiﬁcantly inhibit cell excitability, as observed in
the Xenopus heterologous system, in which 1 mM 2-APB induced
a hyperpolarizing change in the membrane potential of around
−50mV. Itwould be interesting to study the effect of this substance
on native systems, e.g., trigeminal neurons. 2-APB also had con-
siderable effects on the other members of the TREK subfamily,
leading to a fourfold increase in their basal activities. However, as
stated, 2-APB acts upon a plethora of other proteins. For example,
it activates members of the TRPV subfamily, inhibits members
of the TRPC subfamily, and blocks sarco/endoplasmic reticulum
Ca2+-ATPase pumps. Also complicating the interpretation is the
fact that KCNK channels are known to be targets of several second
messengers. Nevertheless, our work with excised patches clearly
shows that the effect of 2-APB on the members of the TREK
subfamily is independent of any cytosolic factor.
It is worth noticing that 2-APB has also been used in sev-
eral systems (e.g., rat dorsal root ganglia) that endogenously
express KCNK10 and KCNK2 as two of their major potassium
background channels (Kang and Kim, 2006). Our results should
be taken into consideration when using these systems to evalu-
ate the effect of 2-APB at concentrations higher than 300 μM.
At these concentrations, 2-APB increases by nearly a factor of
2 the basal activity of hKCNK4 and hKCNK10, while also sig-
niﬁcantly enhancing the basal activity of hKCNK2 (Figures 1G
and 3C). Finally, elucidation of a possible common activating
mechanism for members of this subfamily is deserving of further
study.
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